Idera Pharmaceuticals Inc (IDRA)

1.03 -0.02  -1.90% NASDAQ Jul 30, 20:00 USD
View Full Chart
Price Chart
View All IDRA News

News

View All Events

Events

Date Type Description
08/04/2021 Earnings Results Q2 2021 Earnings Results
04/29/2021 Earnings Results Q1 2021 Earnings Results
03/01/2021 Earnings Results Q4 2020 Earnings Results
10/29/2020 Earnings Results Q3 2020 Earnings Results
08/04/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates.
  • URL: https://www.iderapharma.com
  • Investor Relations URL: http://ir.iderapharma.com/phoenix.zhtml?c=208904&p=irol-irhome
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 04, 2021
  • Last Earnings Release: Apr. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.